Unknown

Dataset Information

0

Whole Exome Sequencing in Coloboma/Microphthalmia: Identification of Novel and Recurrent Variants in Seven Genes.


ABSTRACT: Coloboma and microphthalmia (C/M) are related congenital eye malformations, which can cause significant visual impairment. Molecular diagnosis is challenging as the genes associated to date with C/M account for only a small percentage of cases. Overall, the genetic cause remains unknown in up to 80% of patients. High throughput DNA sequencing technologies, including whole-exome sequencing (WES), are therefore a useful and efficient tool for genetic screening and identification of new mutations and novel genes in C/M. In this study, we analyzed the DNA of 19 patients with C/M from 15 unrelated families using singleton WES and data analysis for 307 genes of interest. We identified seven novel and one recurrent potentially disease-causing variants in CRIM1, CHD7, FAT1, PTCH1, PUF60, BRPF1, and TGFB2 in 47% of our families, three of which occurred de novo. The detection rate in patients with ocular and extraocular manifestations (67%) was higher than in patients with an isolated ocular phenotype (46%). Our study highlights the significant genetic heterogeneity in C/M cohorts and emphasizes the diagnostic power of WES for the screening of patients and families with C/M.

SUBMITTER: Haug P 

PROVIDER: S-EPMC7825129 | biostudies-literature | 2021 Jan

REPOSITORIES: biostudies-literature

altmetric image

Publications

Whole Exome Sequencing in Coloboma/Microphthalmia: Identification of Novel and Recurrent Variants in Seven Genes.

Haug Patricia P   Koller Samuel S   Maggi Jordi J   Lang Elena E   Feil Silke S   Wlodarczyk Agnès A   Bähr Luzy L   Steindl Katharina K   Rohrbach Marianne M   Gerth-Kahlert Christina C   Berger Wolfgang W  

Genes 20210106 1


Coloboma and microphthalmia (C/M) are related congenital eye malformations, which can cause significant visual impairment. Molecular diagnosis is challenging as the genes associated to date with C/M account for only a small percentage of cases. Overall, the genetic cause remains unknown in up to 80% of patients. High throughput DNA sequencing technologies, including whole-exome sequencing (WES), are therefore a useful and efficient tool for genetic screening and identification of new mutations a  ...[more]

Similar Datasets

| S-EPMC8077035 | biostudies-literature
| S-EPMC6120303 | biostudies-other
| S-EPMC8123208 | biostudies-literature
| S-EPMC4418901 | biostudies-literature
| S-EPMC4847612 | biostudies-literature
| S-EPMC4521965 | biostudies-literature
| S-EPMC4849420 | biostudies-literature
| S-EPMC7288463 | biostudies-literature
| S-EPMC6779901 | biostudies-other
| S-EPMC5762310 | biostudies-literature